Coronavirus updates

With vaccine skepticism threatening to shatter pandemic progress, pharma can’t afford to falter

The key factors helping drugmakers develop a vaccine in record time

How autologous cell therapy companies can adapt planning processes to maintain operations amid supply chain disruptions.

It was all smiles at the White House in 2017 when executives from Corning Incorporated visited President Trump’s administration to unveil an innovative new pharmaceutical vial...

How pharma can navigate disruptions by applying Internet of Things technology to supply chains

If the data and recipes were compromised by a foreign adversary, that could be used to corner markets on ingredients, components and tools. The result could be price gouging the...

How a 65-year old drug became the center of partisan divide

Pharma companies are using technology to reinvent the drug discovery process

The response to the COVID-19 crisis is casting a bright reputational halo over the entire industry. But if you’re going to fly close to the sun, you’d better be sure your wings...

After building its domestic infrastructure, Russia's pharma industry looks to go global

How COVID-19 is changing the way the FDA approaches interactions with industry

Pharma’s bumpy race towards a vaccine could offer a fresh start

Can pharma meet its lofty goals for coronavirus vaccine production?

Pharma can use its pandemic response momentum to set the pace for a more prepared future